Plasticity of disseminating cancer cells in patients with epithelial malignancies (Q38021683)

27 August 2017

Plasticity of disseminating cancer cells in patients with epithelial malignancies (English)

1 reference

Catherine Alix-Panabières

27 August 2017

series ordinal

2

object named as

Catherine Alix-Panabières

0 references

Natalia Bednarz-Knoll

series ordinal

1

object named as

Natalia Bednarz-Knoll

0 references

Klaus Pantel

series ordinal

3

object named as

Klaus Pantel

1 reference

27 August 2017

1 December 2012

1 reference

Cancer and Metastasis Reviews

27 August 2017

1 reference

27 August 2017

31

1 reference

27 August 2017

673-687

1 reference

27 August 2017

3-4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-012-9370-z

27 August 2017

0 references

cites work

Dissecting the metastatic cascade

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Clinical relevance and biology of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells and circulating tumor DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Epithelial-to-mesenchymal transitions and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

EMT and dissemination precede pancreatic tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Microenvironmental regulation of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells as a window on metastasis biology in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Elucidating an uncommon disease: inflammatory breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Molecular characterization of circulating tumor cells in breast cancer: challenges and promises for individualized cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Apoptosis of circulating tumor cells in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Does tumour dormancy offer a therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Controversies in clinical cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

The metastatic niche: adapting the foreign soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Metastasis: from dissemination to organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Tracing the tumor lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Isolation of rare cells from cell mixtures by dielectrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Microtentacles tip the balance of cytoskeletal forces in circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Cadherin switch in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Vimentin in cancer and its potential as a molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Cancer invasion and the microenvironment: plasticity and reciprocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

The ins and outs of the epithelial to mesenchymal transition in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Targeting MET in cancer: rationale and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

EMT: a new vision of hypoxia promoting cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

The Snail genes as inducers of cell movement and survival: implications in development and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Role of endoplasmic reticulum stress in epithelial-mesenchymal transition of alveolar epithelial cells: effects of misfolded surfactant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Hypoxia signalling through mTOR and the unfolded protein response in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Molecular markers in circulating tumour cells from metastatic colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Vimentin is secreted by activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Presence of human circulating progenitor cells for cancer stromal fibroblasts in the blood of lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

CD34+ fibrocytes: morphology, histogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Cultured human monocytes secrete fibronectin in response to activation by proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Genetic changes in tumour microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-012-9370-Z

10.1007/S10555-012-9370-Z

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

22733306

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22733306